In September 2012, United States patent reform legislation goes into effect. (The “America Invents Act.” or AIA, Pub.L. No. 112–29; House Report No. 112–98 ,112TH Cong., 1ST Sess. 2011. Referenced as “Report.”) The Report states that the AIA was the first “comprehensive patent law reform in nearly 60 years.” The legislative process took six years […]

What an experience! Following months of intense preparation, the fourth annual Harold G. Fox Moot took place last weekend – much to the enjoyment and satisfied relief of all those involved. With the competition now behind us, the team has a few reflections and words of thanks to offer. This year’s moot problem centered on […]

Advocate-General of the European Court of Justice (ECJ), Yves Bot’s opinion at the end of last year, on SAS Institute Inc. v. World Programming Ltd., was based on the High Court of England and Wales’ preliminary judgment for the same case. Issued on 29 November 2011, Adv.-Gen. Bot focused on specific provisions of Directives 91/250/EEC […]

On January 21, the WHO 130th WHO Executive Board (EB) adopted a resolution for agenda item 6.13 "substandard/spurious/falsely-labelled/falsified/counterfeit medical products” [SFFC]. The resolution is intended to address the growing prevalence of and the health risks associated with “deliberately and fraudulently mislabelled” pharmaceuticals.

It must have been really nice to have worked as an IP expert for the US Trade Representative (USTR) during the 1990s. Almost everything they proposed would become law. The global maximalist agenda had the large international institutions on its side. The golden age of international maximalism saw the creation of the WTO, the TRIPS […]

I was one of the lucky few that had the chance to take part in the inaugural IP Intensive program last term at Osgoode Hall Law School.  Before coming to Osgoode, I was a musician for over a decade, so I was thrilled when I received the news that my placement was at the Society […]